FDA Inspection 930239 — Palo Alto Medical Foundation Reproductive Endocrinology And Infertility
The FDA completed an inspection of Palo Alto Medical Foundation Reproductive Endocrinology And Infertility on Jun 15, 2015 in San Jose, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 15, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Jose, CA (United States)